Answers are grounded in this paper and cite their sources.
Cyanidin-3-O-glucoside (C3G) has antioxidant and anti-inflammatory activity, but its effects in experimental osteoarthritis (OA) remain unclear. We investigated C3G-associated responses in IL-1β-stimulated rat chondrocytes and in rats with monosodium iodoacetate (MIA)-induced OA. Matrix-based proteomic profiling was used to characterize treatment-associated protein-expression changes and to prioritize candidates for targeted experiments. In chondrocytes, C3G partially attenuated IL-1β-associated loss of viability and reduced inflammatory and oxidative-stress markers. C3G treatment was associated with increased NRF2 nuclear accumulation and increased HO-1 and NQO1 expression, whereas NRF2 knockdown attenuated these in vitro responses. In the MIA-induced OA model, C3G treatment was associated with lower OARSI scores, increased COL2A1 and ACAN expression, and reduced MMP13 and ADAMTS5 expression. These findings support the involvement of NRF2-associated signaling in the in vitro response to C3G, but do not establish the upstream mechanism of NRF2 regulation or NRF2 dependence in vivo.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: